IDR-1

• CAT Number: I014861
• CAS Number: 940291-10-1
• Molecular Formula: C65H118N18O15
• Molecular Weight: 1391.74
• Purity: ≥95%
• Synonyms: (2S)-N-[(2S)-1-[[(2S,3S)-1-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carboxamide

IDR-1 (Cat No.:I014861) is a synthetic peptide designed to modulate host immune responses rather than directly targeting pathogens. Unlike traditional antimicrobials, IDR-1 enhances protective innate immunity by promoting chemokine production, immune cell recruitment, and balanced inflammatory responses. It has been shown to reduce excessive inflammation while improving pathogen clearance, making it valuable in infectious disease and immunology research. IDR-1 is also explored for its therapeutic potential in sepsis, chronic inflammation, and wound healing. Its unique immunomodulatory activity highlights new strategies for host-directed antimicrobial therapies.